home / stock / bdx / bdx articles

BDX Articles, Becton Dickinson and Company

Stock Information
Company Name: Becton Dickinson and Company
Stock Symbol: BDX
Market: NYSE
Menu
BDX BDX Quote BDX Short BDX News BDX Articles BDX Message Board
Get BDX Alerts

News, Short Squeeze, Breakout and More Instantly...
BD Bolsters Portfolio With $4.2B Cash Deal For Edwards Lifesciences' Critical Care Group: Details | Benzinga

Shares of medical technology company Becton, Dickinson And Company (NYSE:BDX) are trading higher after the company said it will acquire Edwards Lif...
Biden's New Tariffs On Chinese Imports Are A 'Clear Giveaway' To These Two Tesla Rivals, Jim Cramer Says: 'I Like This Policy' | Benzinga

CNBC host Jim Cramer has highlighted that the recent tariff hikes on Chinese imports, announced by President Joe Biden, will significantly benefit ...

Becton & Dickinson 'Is Well On Its Way To Achieving 2025 Commitments,' Analyst Optimistic On Outlook | Benzinga

On Thursday, BD (Becton, Dickinson and Company) (NYSE:BDX) reported second-quarter sales of $5.04 billion, up 4.6% year ov...

West Pharmaceutical Q1 Earnings Beat, HVP Sales Weak | Benzinga

West Pharmaceutical Services, Inc. (NYSE: WST) reported first-quarter 2024 adjusted earnings per share (ETF:EPS) of $1.56, which beat the Zacks Con...
AngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreement | Benzinga

AngioDynamics, Inc. (NASDAQ:ANGO) signed a settlement agreement with Becton, Dickinson And Company (NYSE:BDX) to resolve all ou...

Jim Cramer Says Don't Sell This Beauty Brand, Believes KKR And Blackstone 'Can Make More Money' | Benzinga

On CNBC’s "Mad Money Lightning Round," Jim Cramer sang the praises of Energy Transfer LP (NYSE: ET), which posted better-than-exp...

FDA Probe On China-Made Syringes: Becton Dickinson Boosts US Syringe Output Following Concerns | Benzinga

Thursday, Becton Dickinson And Co (NYSE:BDX) said it increased production of medical syringes in the U.S. after the FDA recommended not u...
Medical Device Maker Becton Dickinson's Q1 Earnings: Here's Why This Analyst Is Bullish On Long-Term Prospects | Benzinga

Becton, Dickinson, and Company (NYSE:BDX) posted first-quarter 2024 adjusted EPS of $2.68, beating the consensus of $2.40. BD reported sa...

Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst | Benzinga

Needham initiated coverage on Inari Medical Inc (NASDAQ:NARI), noting it as a leader in the very large and underpenetrated market fo...

BD, Hamilton Collaborate to Standardize Single-Cell Multiomics Experiments Using Robotics | Benzinga

Companies to automate a critical step of high-throughput single-cell multiomics experiments FRANKLIN LAKES, N.J., Jan. 23, 2024 /PRNewswire/ -- BD ...
Next 10